1- Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients. Dugast E, Chesneau M, Soulillou JP, Brouard S. Immunol Rev. 2014. Mar;258(1):208-17


 2-Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation, Segovia M 1,2,*, Louvet C 1,*, Charnet P 3, Savina A 4,5, Tilly G 1, Gautreau L 1, Carretero-Iglesia1 L, Beriou G 1, Cebrian I 4,5, Cens T 3, Hepburn L 6, Chiffoleau E 1, Andres Floto R 6, Anegon I 1, Amigorena S 4,5, Hill M 1,2,# and Cuturi MC 1,#. * M.S. and C.L. contributed equally to this work. #: MH and MCC are both senior authors. Am J of transplant, In press.


3-MHC-derived allopeptide recognized by TCR biased-CD8+ Tregs suppresses organ rejection, Picarda E, Bézie S, Venturi V, Echasserieau K, Mérieau E, Delhumeau A, Renaudin K, Brouard S, Bernardeau K, Anegon I and Guillonneau C. J Clin Invest, In press.


4-IL-7 receptor blockade following T cell depletion promotes long-term allograft survival, Mai HL, Boeffard F, Longis J, Danger R, Martinet B, Haspot F, Vanhove B, Brouard S, Soulillou JP, J Clin Invest. 2014. Feb 24.


5-LIMLE, a new molecule over-expressed following activation, is involved in the stimulatory properties of dendritic cells, Le Texier L*1, Durand J*1, Lavault A*, Hulin P, Collin O‡, Le Bras Y‡, Cuturi MC* and Chiffoleau E*. 1 Both authors contributed equally to this work. Plos one, In Press 2014.


6-Increased Th17/Treg ratio in liver chronic graft-versus-host-disease, Malard F, Bossard C, Brissot E, Chevallier P, Guillaume T, Delaunay J, Mosnier JF, Moreau P, Grégoire M, Gaugler B, Mohty M, Bone Marrow Transplant. 2014. Jan 13.


7-Advantages of for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28, Poirier N, Mary C, Le Bas-Bernardet, Daguin V, Belarif L, Chevallier M, et al.MAbs. 2014. 6.


8-Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid. Martin J, Bériou G, Heslan M,  Chauvin C,  Utriainen L,  Aumeunier A, Scott CL,  Mowat A,  Cerovic V,  Houston SA,  Leboeuf M, Hubert FX, Hémont C,  Merad M, Milling S,Josien R, Mucosal Immunol 2014. 7:101-113 


9-Pseudomonas aeruginosa-Induced Apoptosis in Airway Epithelial Cells Is Mediated by Gap Junctional Communication in a JNK-Dependent Manner. Losa D, Köhler T, Bellec J, Dudez T, Crespin S, Bacchetta M, Boulanger P, Hong SS, Morel S, Nguyen TH, van Delden C, Chanson M. 2014. J Immunol. [Epub ahead of print] 


10-Cx26 regulates proliferation of repairing basal airway epithelial cells. Crespin S, Bacchetta M, Bou Saab J, Tantilipikorn P, Bellec J, Dudez T, Nguyen TH, Kwak BR, Lacroix JS, Huang S, Wiszniewski L, Chanson M. 2014. Int J Biochem Cell Biol. [Epub ahead of print]


11-Links between epigenetics and cytoskeleton remodeling during somatic cell reprogramming.David L and Hirsch C. Cell Stem Cell. April 2014, Revue.


12- Phases of reprogramming. David L and Polo J. Stem Cell Research. April 2014, Revue.


13- Codon swapping of zinc finger nucleases confers expression in primary cells and in vivo from a single lentiviral vector. Abarrategui-Pontes C, Créneguy A, Thinard R, Fine EJ, Thepenier V, Fournier Le Ray L, Cradick TJ, Bao G, Tesson L., Podevin G, Anegon I, Nguyen TH. Curr. Gene Ther. In press


14-Effects of a novel ceramic biomaterial on immune modulatory properties and differentiation potential of human mesenchymal stromal cells of different origin. Bassi G*, Guilloton F*, Menard C*, Di Trapani M, Deschaseaux F, Sensebe L, Schrezenmeier H, Giordano R, Bourin P, Dominici M, Tarte K **,Krampera M **, Tissue Engineering 2014, in press. * and ** contributed equally to this work.* 


15-Block copolymer/DNA vaccination induces a strong allergen-specific local response in a mouse model of house dust mite asthma. Rolland-Debord C, Lair D, Roussy-Bihouée T, Hassoun D, Evrard J, Cheminant MA, Chesné J, Braza F, Mahay G, Portero V, Sagan C, Pitard B, Magnan A. PLoS One. 2014 Jan 31;9(1):e85976. doi: 10.1371/journal.pone.0085976. eCollection 2014.





1-Unique B-cell differentiation profile in tolerant kidney transplant patients. Chesneau M, Pallier A, Braza F, Lacombe G, Le Gallou S, Baron D, Giral M, Danger R, Guerif P, Aubert-Wastiaux H, Néel A, Michel L, Laplaud DA, Degauque N, Soulillou JP,  Tarte K, Brouard S, Am. J. transplant 2013


2-Expression of miR-142-5p in Peripheral Blood Mononuclear Cells from Renal Transplant Patients with Chronic Antibody-Mediated Rejection. Danger R, Paul C, Giral M, Lavault A, Foucher Y, Degauque N, Pallier A, Durand M, Castagnet S, Duong Van Huyen JP, Delahousse M, Renaudin K, Soulillou JP, Brouard S, PLoS One. 2013;8(4)


3- Regulatory B Cells and Tolerance in Transplantation: From Animal Models to Human. Chesneau M, Michel L, Degauque N, Brouard S, Front Immunol. 2013 Dec 31;4:497. 2013


4- Expression of miR-142-5p in Peripheral Blood Mononuclear Cells from Renal Transplant Patients with Chronic Antibody-Mediated Rejection.Danger R, Paul C, Giral M, Lavault A, Foucher Y, Degauque N, Pallier A, Durand M, Castagnet S, Duong Van Huyen JP, Delahousse M, Renaudin K, Soulillou JP, Brouard S, PLoS One. 2013;8(4)


5- Endothelial cell activation and proliferation modulate NKG2D activity by regulating MICA expression and shedding. Chauveau A,  Tonnerre P, Pabois A,  Gavlovsky PJ, Chatelais M, Coupel  S,  Charreau B, J Innate Immun. 2013 Jul 16. 


6-Long-Term IgG Response to Porcine Neu5Gc Antigens without Transmission of PERV in Burn Patients Treated with Porcine Skin Xenografts. Scobie L, Padler-Karavani V, Le Bas-Bernardet S, Crossan C, Blaha J, Matouskova M, Hector RD, Cozzi E, Vanhove B, Charreau B, Blancho G, Bourdais L, Tallacchini M, Ribes JM, Yu H, Chen X, Kracikova J, Broz L, Hejnar J, Vesely P, Takeuchi Y, Varki A, Soulillou JP, J Immunol. 2013 Sep 15;191(6):2907-15


7- Differential roles of Hath1, MUC2 and P27Kip1 in relation with gamma-secretase inhibition in human colonic carcinomas : a translational study. Souazé F, Bou-Hanna C,  Kandel C,  Leclair F,  Devallière J, Charreau B,  Bézieau S, Mosnier JF, Laboisse CL,  PLoS One. 2013;8(2).


8-Extract from Mimosa pigra attenuates chronic experimental pulmonary hypertension. Rakotomalala G, Agard C,  Tonnerre P, Tesse A, Derbré S, Michalet S,  Hamzaoui J,  Rio M,  Cario-Toumaniantz C, Richomme P,  Charreau B, Loirand, Pacaud P, Journal of Ethnopharmacology 2013, Jun 21;148(1):106-16.


9- MICA Variant Promotes Allosensitization after Kidney Transplantation. Tonnerre P, Gérard N, Chatelais M, Poli C,  Allard S, Cury S, Bressollette C, Cesbron-Gautier A, Charreau B, J Am Soc Nephrol. May;24(6):954-66.


10- Impact of notch signaling on inflammatory responses in cardiovascular disorders. Quillard T & Charreau B, Int. J. Mol 2013 Mar 26;14(4):6863-88.


11-No tumour-initiating risk associated with scaav transduction in newborn rat liver. Gauttier V, Pichard V,  Aubert D,  Kaeppel C, Schmidt M,  Ferry N, Conchon S, Gene There 2013.


12-Fetal fibroblasts and keratinocytes with immunosuppressive properties for allogeneic cell-based wound therapy, Zuliani T, Saiagh S, Knol A.C, Esbelin J, Dréno B, PLOS One, 2013, 8(7).


13- Increased plasmacytoid dendritic cells and RORγt-expressing immune effectors in cutaneous acute graft-versus-host disease. Malard F, Bossard C, Brissot E, Chevallier P, Guillaume T, Delaunay J, Mosnier JF, Moreau P, Grégoire M, Gaugler B, Mohty M, J Leukoc Biol. 2013 Aug 29.


14-RILES, a novel method for temporal analysis of the in vivo regulation of miRNA expression, Ezzine S, Vassaux G, Pitard B, Barteau B, Malinge JM, Midoux P, PichonP, Baril P, Nucleic Acids Research. (2013) 41.


15-Reliability of the nanopheres-DNA immunization technology to produce polyclonal antibodies directed against human neogenic proteins. Arnaoty A, Gouilleux-Gruart V, Casteret S, Pitard B, Bigot Y, Lecomte T. Mol Genet Genomics. (2013) 288: 347-63.


16-DNA nanocarriers for systemic administration: characterization and in vivo bioimaging in healthy mice.David S, Passirani C, Carmoy N, Morille M, Mevel M, Chatin B, Benoit JP, Montier T, Pitard B, Mol Ther Nucleic Acids. (2013) Jan 8;2.


17-Characterization of the human CD4(+) T-cell repertoire specific for major histocompatibility class I-restricted antigens. Legoux F, Gautreau L, Hesnard L, Leger A, Moyon M, Devilder MC, Bonneville M, Saulquin X. Eur J Immunol. 2013 Dec 43(12):3244-53.


 18-Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls. Ménard C, Pacelli L, Bassi G, Dulong J, Bifari F, Bezier I, Zanoncello J, Ricciardi M, Latour M, Bourin P, Schrezenmeier H, Sensebé L, Tarte K*, Krampera M* (*equal contribution) Stem Cells Dev. 2013; 22:1789-801.


19-Comparative study of immune regulatory properties of stem cells derived from different tissues. Di Trapani M, Bassi G, Ricciardi M, Fontana E, Bifari F, Pacelli L, Giacomello L, Pozzobon M, Féron F, De Coppi P, Anversa P, Fumagalli G, Decimo I, Ménard C, Tarte K, Krampera M, Stem Cells Dev. 2013; 22:2990-3002.


20-Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application. Ménard C, Tarte K, Stem Cell Res Ther. 2013;4:64.


21-Immunological characterization of multipotent mesenchymal stromal cells - The International Society for Cellular Therapy (ISCT) working proposal. Krampera M, Galipeau J, Shi Y, Tarte K, Sensebe L; MSC Committee of the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013; 15:1054-61.


22-Costimulation Differentially Controls Immune Synapses and Function of Human Regulatory and Conventional T-Cells, Dilek N, Poirier N, Hulin P, Coulon F, Mary C, Ville S, et al. Targeting CD28, CTLA-4 and PD-L1. PLoS One. 2013: 8.


23-Antagonist properties of monoclonal antibodies targeting human CD28. Role of valency and the heavy-chain constant domain. Mary C, Coulon F, Poirier N, Dilek N,  Martinet B, Blancho G, Vanhove B,  mAbs 2013, 5: 47-55. 


24-Survival and Differentiation of Adenovirus-Generated Induced Pluripotent Stem Cells Transplanted into the Rat Striatum. Fink KD, Rossignol J, Lu M, Leveque X, Hulse TD, Crane AT, Nerriere-Daguin V, Wyse RD, Starski PA, Schloop MT, Dues DJ, Witte SJ, Song C, Vallier L, Nguyen TH, Naveilhan P, Anegon I, Lescaudron L, Dunbar GL. 2013.  Cell Transplant. [in press] IF 2010 : 6.2


25-Editorial (Hot Topic: Stem-Cell Reprogramming for Medicine), Nguyen TH. 2013. Guest Editor. Invited guest editor for this special issue with 8 reviews. Curr Gene Ther., 13(2):71-2, IF 2010 : 5.318 



1-Cell therapy using tolerogenic dendritic cells in transplantation. Moreau A, Varey E, Bouchet-Delbos L, Cuturi MC, Transplant Res. Sept 2012


2-Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials. Moreau A, Varey E, Bériou G, Hill M, Bouchet-Delbos L, Segovia M, Cuturi MC, Front Immunol. 2012


3-Restoration of Vision in the pde6β-deficient Dog, a Large Animal Model of Rod-cone Dystrophy, Petit L, Lheriteau E, Weber M, Le Meur G, Deschamps JY, Provost N, Mendes-Madeira A, Libeau L, Guihal C, Colle MA, Moullier P, Rolling F. Mol Ther. 2012 ; 20(11):2019-2013.